Delivery Order SPE2DB20D1109-SPE2DB21FQ06F
- Not listed
- This federal contract award, valued at $2,225.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,583 units of Metronidazole 500 mg tablets. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 25, 2023. The contract was awarded on October 24, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., to deliver Metronidazole 500 mg tablets to the Defense Logistics Agency (DLA). The Firm Fixed Price Delivery Order, valued at $1,698.92, has an ultimate completion date of December 11, 2023. The contract is not set aside for any specific type of business. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The current Delivery Order has a ceiling value of $1,378.43...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.90 to Amerisourcebergen Drug Corp for 500 tablets of Metronidazole 500 mg, with a completion date of January 29, 2026. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This...
- This delivery order, awarded July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, procures Metronidazole tablets in quantities of 100 units with a ceiling value of $2,430.32 and an ultimate completion date of August 18, 2025. The contract employs firm fixed pricing and was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $1,046.90, is for the supply of Metronidazole Tablets, a pharmaceutical product, to support military treatment programs and facilities. The award has no set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,275.82 to AmerisourceBergen Drug Corp for the supply of Metronidazole 500 mg tablets (500-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's broader federal contract portfolio. The pharmaceutical product will be delivered to the company's corporate...
- The Defense Logistics Agency (DLA) awarded a $7,258.98 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Metronidazole 500 mg. The contract, which is not set-aside, was awarded on October 31, 2025, with an ultimate completion date of November 3, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania under a firm fixed price arrangement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Metronidazole 0.75% Lotion, a pharmaceutical product, with a ceiling value of $1,218.44. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Metronidazole 0.75% cream in 45-gram units, valued at $1,590.68. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carried no set-aside...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FQ06FDelivery Order
This federal contract award, with a ceiling value of $2,421.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4554821860 Metronidazole 500 mg tablets and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare needs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/17/21 |